800821C

18:0-16:0 DG

1-octadecanoyl-2-hexadecanoyl-sn-glycerol, chloroform

• Synonym(e): 1-stearoyl-2-palmitoyl-sn-glycerol; DG(18:0/16:0/0:0); 110883
• Empirische Formel (Hill-System): C₃₇H₇₂O₅
• CAS-Nummer: 14015-55-5
• Molekulargewicht: 596.96
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 5 mL (800821C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 800821C
• Konzentration: 1 mg/mL (800821C-5mg)
• Lipid-Typ: neutral glycerides; neutral lipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• InChI: 1S/C37H72O5/c1-3-5-7-9-11-13-15-17-18-20-21-23-25-27-29-31-36(39)41-34-35(33-38)42-37(40)32-30-28-26-24-22-19-16-14-12-10-8-6-4-2/h35,38H,3-34H2,1-2H3
• InChIKey: VYQDALBEQRZDPL-UHFFFAOYSA-N

Beschreibung

Allgemeine Beschreibung

18:0-16:0 DG, also called 1-stearoyl-2 palmitoyl-sn-glycerol diacylglycerol (DAG), comprises a glycerol backbone with two carboxylic acids covalently linked to the sn-1 and sn-2 position.

Anwendung

18:0-16:0 DG may be used in the standard curve generation for liquid chromatography-mass spectrometry (LC-MS) analysis.

Biochem./physiol. Wirkung

18:0-16:0 DG, also called 34:0-DG, is phosphorylated by diacylglycerol kinase δ at high glucose levels. DG participates in protein kinase C activation and is a second messenger for many signaling events.

Verpackung

30 mL Amber Narrow Mouth Glass Bottle with Screw Cap (800821C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• WGK: WGK 3